Health care stocks were declining Thursday afternoon, with the NYSE Health Care Index down 0.8% and the Health Care Select Sector SPDR Fund (XLV) shedding 0.9%. The iShares Biotechnology ETF (IBB) fell 1.1%.
In corporate news, AC Immune (ACIU) shares surged nearly 20% after the company said a phase 2 trial of its potential early Parkinson's disease treatment yielded "positive" interim safety and immunogenicity results.
Immutep (IMMP) shares jumped 10%. The company reported positive data from a phase 1 trial assessing eftilagimod alpha plus Keytruda and chemotherapy to treat metastatic non-squamous non-small cell lung cancer.
Oscar Health (OSCR) shares soared 18% after Joshua Kushner, its director, co-founder and vice chairman, bought about 1.1 million shares.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。